comparemela.com
Home
Live Updates
Regeneron Files Antitrust Lawsuit Accusing Amgen of Engaging
Regeneron Files Antitrust Lawsuit Accusing Amgen of Engaging
Regeneron Files Antitrust Lawsuit Accusing Amgen of Engaging in a Persistent Exclusionary Campaign to Deny Patients Access to Praluent® | Goodwin
Late last week, Regeneron Pharmaceuticals, Inc. filed an antitrust complaint against Amgen Inc. in the U.S. District Court for the District of Delaware. Regeneron alleges that “Amgen...
Related Keywords
New York ,
United States ,
Delaware ,
California ,
Amgen Enbrel ,
Regeneron Praluent ,
Amgen Repatha ,
Amgen ,
Regeneron Pharmaceuticals Inc ,
Amgen Inc ,
Us District Court ,
Party Payors ,
Party Payor ,
Regeneron Pharmaceuticals ,
Third Party Payors ,
Third Party Payor ,
Sub Market Through Bundling ,
Attempted Monopolization ,
Sub Market Through Below Cost Pricing ,
Unreasonable Restraint ,
Exclude Praluent ,
Unfair Competition Law ,
Unfair Practices Act ,
Cartwright Act ,
Donnelly Act ,
General Business Law ,
Tortious Interference ,
Prospective Business ,
Big Molecule Watch ,